Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies (Q34192717)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies |
scientific article |
Statements
1 reference
Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies (English)
1 reference
Lesko LJ
1 reference
Atkinson AJ Jr
1 reference
1 January 2001
1 reference
1 reference
Identifiers
1 reference